US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apnimed

27.45

-0.3600-1.29%

Post-market: 27.450.00000.00%16:10 EDT

Volume:232.87K

Turnover:6.36M

Market Cap:1.09B

PE:-34.36

High:28.36

Open:27.36

Low:26.44

Close:27.81

52wk High:35.29

52wk Low:16.12

Shares:39.82M

Float Shares:12.00M

Volume Ratio:0.61

T/O Rate:1.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7990

EPS(LYR):-23.7581

ROE:--

ROA:-36.94%

PB:-3.59

PE(LYR):-1.16

Loading ...

Overview Company News Filings

Apnimed Grants Inducement Stock Options for 428,428 Shares at USD 26.85 Each

Apnimed, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

U.S. Small Caps Drop; Apnimed Posts Biggest Loss

Apnimed, Inc. : Bofa Global Research Initiates Coverage with Buy Rating and Price Objective $41.00

THOMSON REUTERS

Apnimed Initiated at Buy by B of a Securities

LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target

MT Newswires Live

Apnimed initiated with an Overweight at Cantor Fitzgerald

Apnimed initiated with an Outperform at LifeSci Capital

Apnimed initiated with a Buy at BofA

U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials

Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million

Insider Move: Apnimed Director Makes Bold New Investment

Apnimed IPO Raises $220.8 Million at $16 Per Share

Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Apnimed Adopts New IPO-Era Bylaws with Advance Notice Rules for Shareholder Proposals

Apnimed Director Paul J. Sekhri Acquires $200,000 in Common Shares

Apnimed opens at $22.00, IPO priced at $16.00

NASDAQ Trade Halt Volatility Trading Pause at 11:49 Am

Stock Track | Apnimed Soars 37.5% in Intraday Debut After Upsized IPO Priced at Top of Range

Sleep Apnea Pill Developer Apnimed Poised to Jump in Debut After Upsized IPO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/APMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","market":"US","secType":"STK","nameCN":"Apnimed","latestPrice":27.45,"timestamp":1788552000000,"preClose":27.81,"halted":0,"volume":232870,"hourTrading":{"tag":"盘后","latestPrice":27.45,"preClose":27.45,"latestTime":"16:10 EDT","volume":1270,"amount":34861.5,"timestamp":1788552604694,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012944983818770206,"floatShares":12000000,"shares":39823183,"eps":-0.799,"marketStatus":"Post-Mkt","change":-0.36,"latestTime":"09-04 16:27:30 EDT","open":27.36,"high":28.355,"low":26.435,"amount":6361561,"amplitude":0.06904,"askPrice":28.1,"askSize":350,"bidPrice":26.93,"bidSize":74,"shortable":3,"etf":0,"ttmEps":-0.799,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788566400000},"marketStatusCode":4,"adr":0,"listingDate":1785470400000,"exchange":"NASDAQ","adjPreClose":27.81,"preHourTrading":{"tag":"盘前","latestPrice":27.36,"preClose":27.81,"latestTime":"09:28 EDT","volume":164,"amount":4488.840228,"timestamp":1788528480120,"change":-0.45,"changeRate":-0.016181,"amplitude":0.016181},"postHourTrading":{"tag":"盘后","latestPrice":27.45,"preClose":27.45,"latestTime":"16:10 EDT","volume":1270,"amount":34861.5,"timestamp":1788552604694,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.612818},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","floatShares":12000000,"roa":"-36.94%","roe":"--","lyrEps":-23.758134,"volumeRatio":0.612818,"shares":39823183,"dividePrice":0,"high":28.355,"amplitude":0.06904,"preClose":27.81,"low":26.435,"week52Low":16.12,"pbRate":"-3.59","psRate":"9.10","week52High":35.29,"institutionHeld":0,"latestPrice":27.45,"committee":-0.650943,"eps":-0.799,"divideRate":0,"volume":232870,"delay":0,"ttmEps":-0.799,"open":27.36,"prevYearClose":16,"prevWeekClose":29.71,"prevMonthClose":26.25,"prevQuarterClose":16,"fiveDayClose":29.71,"twentyDayClose":27,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APMD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1788408000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APMD","date":"2026-09-03","current":-34.355444,"percent":0.217391,"low":-12.845073,"twenty":-12.066846,"median":-9.91611,"eighty":-8.260629,"high":-7.725991,"avg":-10.110658,"sd":1.791772,"marketCap":1542427182},"quantilePoints":[{"date":"2026-08-07","current":-8.661063,"twenty":-8.320585,"median":-7.986942,"eighty":-7.766377,"marketCap":1110270342},{"date":"2026-08-14","current":-8.943759,"twenty":-8.664791,"median":-8.256435,"eighty":-7.766377,"marketCap":1146509438},{"date":"2026-08-21","current":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"marketCap":1582331874},{"date":"2026-08-28","current":-12.417048,"twenty":-11.890448,"median":-9.403529,"eighty":-8.185761,"marketCap":1591753815},{"date":"2026-09-03","current":-12.032258,"twenty":-12.066846,"median":-9.91611,"eighty":-8.260629,"marketCap":1542427182}],"updateTime":1788553650024},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665591073","title":"Apnimed Grants Inducement Stock Options for 428,428 Shares at USD 26.85 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665591073","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665591073?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552077,"startTime":"0","endTime":"0","summary":"Apnimed grants inducement stock options for 428,428 shares at USD 26.85 eachApnimed granted non-qualified stock options covering 428,428 shares to 10 new non-executive employees under its 2026 Inducem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL4P3wVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BCDF","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","BK4112","BK4007","SG9999014021.USD","LU2210149790.SGD","NDAQ","BK4585","LU2210150020.SGD","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665359120","title":"Apnimed, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665359120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665359120?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA6DBLRJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664833358","title":"U.S. Small Caps Drop; Apnimed Posts Biggest Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2664833358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664833358?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:20","pubTimestamp":1788207600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies fell Monday, as the Russell 2000 Index dropped 0.5%, and the S&P Small Cap 600 Index was down 0.7%.Among companies with a market value of $1 billion to $6.7 billion, Apnimed Inc. was the biggest laggard during the session, dropping 12%, followed by shares of Herbalife Ltd., which dropped 12%. Shares of Lindblad Expeditions Holdings Inc. dropped 10%, Falcon's Beyond Global Inc. shares plunged 9.4%, and Latigo Biotherapeutics Inc. plunged 9.1%.Evolution Metals & Technologies Corp. was the best performer, surging 18%, followed by Standard Nuclear Inc., which jumped 14%. Strive Inc. Cl A shares surged 11%, Obsidian Therapeutics Inc. jumped 7.4%, and shares of Avis Budget Group Inc. surged 6.8%.Major stock indexes in the U.S. fell Monday with the Nasdaq Composite Index declining 0.1%. Meanwhile, the S&P 500 Index declined 0.3%, and the Dow Jones Industrial Average declined 0.7%.Data source: Dow","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173932","title":"Apnimed, Inc. : Bofa Global Research Initiates Coverage with Buy Rating and Price Objective $41.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173932?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:10","pubTimestamp":1787656244,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nAZN4TG5UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736246","title":"Apnimed Initiated at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736246?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:59","pubTimestamp":1787655540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APMD/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273683","title":"LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273683?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:46","pubTimestamp":1787654763,"startTime":"0","endTime":"0","summary":"LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735746","title":"Apnimed initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:35","pubTimestamp":1787654119,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Apnimed (APMD) with an Overweight rating and $60 price target Published first on TheFly – the ultimate sour...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735898","title":"Apnimed initiated with an Outperform at LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735898?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:20","pubTimestamp":1787653215,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Francois Brisebois initiated coverage of Apnimed (APMD) with an Outperform rating and $50 price target Published first on T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662358957","title":"Apnimed initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662358957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662358957?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:15","pubTimestamp":1787652909,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Gerberry initiated coverage of Apnimed (APMD) with a Buy rating and $41 price target Sole asset Oxnimbi, an oral therapy for obs...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781491","title":"U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781491?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:27","pubTimestamp":1787642845,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan MaterialsAug 25 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Masco","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL8N44M0AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KNF","BXP","INSM","LRCX","FAC","FIVE","VMC","SMHX","AMD","GTLB","AMAT","FBIN","FLNC","LEU","TEK","ALB","CLMT","ANAB","IETC","MAS","SHW","FIS","DT","FMC","KDK","MRSH","GPN","KRO","CHYM","EMSF","MRVL","HON","BKR","GTEK","JBTM","ACAD","WMS","MLM","CLSE","CURB","EXP","PTF","AWI","CSL","DNLI","MU","DAMD","ACM","AMRZ","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657679578","title":"Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657679578","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657679578?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:20","pubTimestamp":1785961207,"startTime":"0","endTime":"0","summary":"Morningside Venture Investments reports Apnimed common share acquisition valued at $5 millionMorningside Venture Investments, a 10% owner of Apnimed, converted holdings into 6,840,213 shares of common","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL6MXLgv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656713586","title":"Insider Move: Apnimed Director Makes Bold New Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2656713586","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656713586?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:08","pubTimestamp":1785809300,"startTime":"0","endTime":"0","summary":"New insider activity at Apnimed, Inc. ( ($APMD) ) has taken place on August 3, 2026. Director Paul Sekhri of Apnimed, Inc. has significantly increa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-apnimed-director-makes-bold-new-investment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-apnimed-director-makes-bold-new-investment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656025303","title":"Apnimed IPO Raises $220.8 Million at $16 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656025303","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656025303?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:46","pubTimestamp":1785790016,"startTime":"0","endTime":"0","summary":"Apnimed IPO raises $220.8 million at $16 per shareApnimed closed an upsized IPO of 13,800,000 common shares at USD 16 per share.Deal size included 1,800,000 shares from the full exercise of the underw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLtt0cS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4588","LU2210150020.SGD","NDAQ","APMD","IE00BN0W2V16.EUR","LU0314104364.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BCDF","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656307836","title":"Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656307836","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656307836?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:35","pubTimestamp":1785789300,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Aug.  03, 2026  (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercializati","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337925/0/en/Apnimed-Announces-Closing-of-Upsized-Initial-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD","OSA","BK4082","IPOS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656090593","title":"Apnimed Adopts New IPO-Era Bylaws with Advance Notice Rules for Shareholder Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2656090593","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656090593?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:03","pubTimestamp":1785787399,"startTime":"0","endTime":"0","summary":"Apnimed adopts new IPO-era bylaws with advance notice rules for shareholder proposalsApnimed adopted second amended and restated bylaws effective Aug. 3, 2026, tied to its initial public offering.The ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3LMVj0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656097513","title":"Apnimed Director Paul J. Sekhri Acquires $200,000 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656097513","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656097513?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787308,"startTime":"0","endTime":"0","summary":"Apnimed director Paul J. Sekhri acquires $200,000 in common sharesApnimed director Paul J. Sekhri reported buying 12,500 common shares at USD 16, lifting his direct holding to 12,500 shares.He also re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL5CHx8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apnimed Director Paul J. Sekhri Acquires $200,000 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656398107","title":"Apnimed opens at $22.00, IPO priced at $16.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398107?lang=en_us&edition=fundamental","pubTime":"2026-08-01 00:15","pubTimestamp":1785514553,"startTime":"0","endTime":"0","summary":"Apnimed (APMD) priced 12M shares at $16.00. The deal size was increased to 12M shares from 10M shares of common stock and priced at the high-end of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-opens-at-22-00-ipo-priced-at-16-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-opens-at-22-00-ipo-priced-at-16-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REDS","IPOS","KCE","FRHC","BK4127","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655607223","title":"NASDAQ Trade Halt Volatility Trading Pause at 11:49 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2655607223","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655607223?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:49","pubTimestamp":1785512983,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 11:49 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nAQN2MCM7D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184287020","title":"Stock Track | Apnimed Soars 37.5% in Intraday Debut After Upsized IPO Priced at Top of Range","url":"https://stock-news.laohu8.com/highlight/detail?id=1184287020","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184287020?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:46","pubTimestamp":1785512783,"startTime":"0","endTime":"0","summary":"Shares of Apnimed (APMD) surged 37.5% in intraday trading on Friday, as the clinical-stage biotech made a strong debut on the Nasdaq Global Select Market. The stock opened significantly higher than...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655601183","title":"Sleep Apnea Pill Developer Apnimed Poised to Jump in Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2655601183","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655601183?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:32","pubTimestamp":1785511920,"startTime":"0","endTime":"0","summary":"BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO** Late-stage biotech ApnimedAPMD.Oon track to jump in Nasdaq debut on Fri after above-target IPO** APMD shares recently indicated to open at $22 vs $16 offering price** Cambridge, Massachusetts-based firm late Thurs sold 12 mln shares for $192 mln raise** Co had marketed deal size of 10 mln shares at $14-$16** Its sole clinical product candidate, AD109 , is a once-daily pill taken at night to treat obstructive sleep apnea , a condition in which the airway repeatedly collapses during sleep, lowering oxygen levels and disrupting breathing** Morningside, Alpha Wave Ventures and Japanese pharma Shionogi & Co4507.Tare its largest shareholders, per the prospectus** BofA, Evercore, Cantor Fitzgerald and LifeSci Capital joint bookrunners on the IPO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL6N43X12X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","EVR","APMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}